• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags Novo Nordisk A/S Eli Lilly and Co Uber Technologies Inc
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags World News Business Health care industry
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
May 20, 2024
Tags Technology Business News Health care industry
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags Eli Lilly and Co Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags Biotech and Pharmaceuticals Health care industry Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags Biotech and Pharmaceuticals Health care industry US: News
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags Biotech and Pharmaceuticals Health care industry Apple Inc
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags Business Companies Biotechnology
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
May 02, 2024
Tags Health & Science Breaking news Amgen Inc
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
May 02, 2024
Tags Pharmaceuticals Earnings Novo Nordisk A/S
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
Tags Business Breaking News: Politics Biotechnology
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
April 24, 2024
Tags Breaking News: Politics Policy Biotech and Pharmaceuticals
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
April 24, 2024
Tags Novo Nordisk A/S Social issues Breaking news
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
Tags Novo Nordisk A/S Starbucks Corp Eli Lilly and Co
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
April 17, 2024
Tags Companies Biotechnology Business
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
April 17, 2024
Tags Business News Health care industry US: News
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
April 12, 2024
Tags Business Companies Biotechnology
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
April 04, 2024
Tags Companies Science Biotechnology
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
April 04, 2024
Tags Food and drink Health & Science Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags Health & Science AstraZeneca PLC Novo Nordisk A/S
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
Tags Business Biotechnology Science
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
March 27, 2024
Tags Health & Science Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
March 26, 2024
Tags Biotech and Pharmaceuticals US: News Health care industry
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
Tags Amgen Inc Health & Science Business
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
March 23, 2024
Tags U/S/ Markets Stock markets Artificial intelligence
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
Tags Health & Science Pharmaceuticals Social issues
From CNBC.com News
Cramer's Lighting Round: Arm is a buy
March 22, 2024
Tags Novo Nordisk A/S General Electric Co SoundHound AI Inc
From CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
March 21, 2024
Tags Social issues Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags 89Bio Inc Health care industry Madrigal Pharmaceuticals Inc
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap